DRTS vs SGP: stock comparison and AI forecast
Alpha Tau Medical Ltd. (DRTS) and Spyglass Pharma, Inc. (SGP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DRTS Alpha Tau Medical Ltd.
- Market Cap
- $1.13B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SGP Spyglass Pharma, Inc.
- Market Cap
- $1.13B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DRTS and SGP have similar market capitalizations ($1.13B and $1.13B).
- DRTS carries 0.37 times debt per unit of equity, against 0.05 times for SGP.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DRTS | SGP |
|---|---|---|
| Market Cap | $1.13B | $1.13B |
| P/B Ratio | 14.65x | 4.84x |
| EPS | $-0.98 | – |
| Book Value/Share | $0.88 | $6.95 |
Profitability & Margins
| Metric | DRTS | SGP |
|---|---|---|
| ROE | -96.5% | – |
| ROA | -70.4% | – |
| ROIC | -82.3% | – |
| Tax Rate | -0.2% | – |
Financial Health
| Metric | DRTS | SGP |
|---|---|---|
| Current Ratio | 7.45x | 25.06x |
| D/E Ratio | 0.37x | 0.05x |
| Financial Leverage | 1.37x | 1.05x |
| Interest Coverage | -95.6x | – |
| Working Capital | $68M | $227M |
Cash Flow
| Metric | DRTS | SGP |
|---|---|---|
| Operating Cash Flow | -$46M | – |
Income Statement
| Metric | DRTS | SGP |
|---|---|---|
| Operating Income | -$78M | – |
| Net Income | -$74M | – |
| R&D Expense | $59M | – |
Dividend & Shareholder Information
| Metric | DRTS | SGP |
|---|---|---|
| Shares Outstanding | 88M | 33M |
DRTS vs SGP: stock comparison and AI forecast
Which is bigger, DRTS or SGP?
DRTS and SGP have similar market capitalizations ($1.13B and $1.13B).
Which one does Intratio's AI model rank higher, DRTS or SGP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.